Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur R Thompson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood|June 25, 2009
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responsesRuth A Ettinger, Eddie A James, William W Kwok, et al.
Blood Advances|February 16, 2018
FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activityRuth A Ettinger, Joseph A Liberman, Devi Gunasekera, et al.
Blood|July 30, 2016
T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoireRuth A Ettinger, Pedro Paz, Eddie A James, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A micePeiqing Ye, Arthur R Thompson, Rita Sarkar, et al.
Blood|August 29, 2009
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia miceCarol H Miao, Benjamin R Harmeling, Steven F Ziegler, et al.
Plos One|January 24, 2015
Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibodyJasper C Lin, Ruth A Ettinger, Jason T Schuman, et al.
Blood|January 28, 2012
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysisSamantha C Gouw, H Marijke van den Berg, Johannes Oldenburg, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood|June 25, 2009
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responsesRuth A Ettinger, Eddie A James, William W Kwok, et al.
Blood Advances|February 16, 2018
FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activityRuth A Ettinger, Joseph A Liberman, Devi Gunasekera, et al.
Blood|July 30, 2016
T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoireRuth A Ettinger, Pedro Paz, Eddie A James, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A micePeiqing Ye, Arthur R Thompson, Rita Sarkar, et al.
Blood|August 29, 2009
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia miceCarol H Miao, Benjamin R Harmeling, Steven F Ziegler, et al.
Plos One|January 24, 2015
Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibodyJasper C Lin, Ruth A Ettinger, Jason T Schuman, et al.
Blood|January 28, 2012
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysisSamantha C Gouw, H Marijke van den Berg, Johannes Oldenburg, et al.
The New England Journal of Medicine|April 17, 2009
Inhibitors of factor VIII in black patients with hemophiliaKevin R Viel, Afshin Ameri, Thomas C Abshire, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Pageof 2